BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matricon J, Barnich N, Ardid D. Immunopathogenesis of inflammatory bowel disease. Self Nonself. 2010;1:299-309. [PMID: 21487504 DOI: 10.4161/self.1.4.13560] [Cited by in Crossref: 122] [Cited by in F6Publishing: 117] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Rondini EA, Bennink MR. Microarray Analyses of Genes Differentially Expressed by Diet (Black Beans and Soy Flour) during Azoxymethane-Induced Colon Carcinogenesis in Rats. J Nutr Metab 2012;2012:351796. [PMID: 22496968 DOI: 10.1155/2012/351796] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
2 Jiang X, Huang X, Yang Z, Wang S, Xie W, Miao L, Tang L, Huang Z. Iguratimod ameliorates inflammatory responses by modulating the Th17/Treg paradigm in dextran sulphate sodium-induced murine colitis. Molecular Immunology 2018;93:9-19. [DOI: 10.1016/j.molimm.2017.10.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
3 Gomes RG, Brito CAAD, Martinelli VF, Santos RND, Gomes FODS, Peixoto CA, Crispim JO, Diniz GTN, Donadi EA, Lucena-silva N. HLA-G is expressed in intestinal samples of ulcerative colitis and Crohn’s disease patients and HLA-G5 expression is differentially correlated with TNF and IL-10 cytokine expression. Human Immunology 2018;79:477-84. [DOI: 10.1016/j.humimm.2018.03.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kim E, Bae J, Lee J, Shin J, Seok PR, Kim Y, Yoo S. Purification and characterization of turanose, a sucrose isomer and its anti-inflammatory effects in dextran sulfate sodium (DSS)-induced colitis model. Journal of Functional Foods 2019;63:103570. [DOI: 10.1016/j.jff.2019.103570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gholam-mostafaei FS, Yadegar A, Aghdaei HA, Azimirad M, Daryani NE, Zali MR. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease. Current Research in Translational Medicine 2020;68:125-30. [DOI: 10.1016/j.retram.2020.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012;36:1009-31. [DOI: 10.1111/apt.12080] [Cited by in Crossref: 125] [Cited by in F6Publishing: 122] [Article Influence: 12.5] [Reference Citation Analysis]
7 Walia D, Kaur G, Jaggi AS, Bali A. Exploring the therapeutic potential of sodium benzoate in acetic acid-induced ulcerative colitis in rats. J Basic Clin Physiol Pharmacol 2019;30. [PMID: 31469656 DOI: 10.1515/jbcpp-2019-0086] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol. 2011;8:523-531. [PMID: 21844910 DOI: 10.1038/nrgastro.2011.133] [Cited by in Crossref: 204] [Cited by in F6Publishing: 189] [Article Influence: 18.5] [Reference Citation Analysis]
9 Ashour RH, Hazem NM, AbdElfattah AA, El-Kady RA, Elmasry A. Pentosan Polysulfate Sodium augments the therapeutic effect of 5-Aminosalicylic Acid in DSS colitis model; the role of IL-35 expression. Int Immunopharmacol 2022;106:108620. [PMID: 35247859 DOI: 10.1016/j.intimp.2022.108620] [Reference Citation Analysis]
10 Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep 2020;47:3053-63. [PMID: 32086718 DOI: 10.1007/s11033-020-05318-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
11 Kesharwani SS, Ahmad R, Bakkari MA, Rajput MK, Dachineni R, Valiveti CK, Kapur S, Jayarama Bhat G, Singh AB, Tummala H. Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): Formulation development, characterization and pharmacological evaluation. Journal of Controlled Release 2018;290:165-79. [DOI: 10.1016/j.jconrel.2018.08.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
12 Ranjha R, Meena NK, Singh A, Ahuja V, Paul J. Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs. PLoS One 2017;12:e0173447. [PMID: 28301487 DOI: 10.1371/journal.pone.0173447] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
13 Xiong Y, Wang J, Chu H, Chen D, Guo H. Salvianolic Acid B Restored Impaired Barrier Function via Downregulation of MLCK by microRNA-1 in Rat Colitis Model. Front Pharmacol 2016;7:134. [PMID: 27303297 DOI: 10.3389/fphar.2016.00134] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
14 Anfray C, Mainini F, Andón FT. Nanoparticles for immunotherapy. Colloids for Nanobiotechnology - Synthesis, Characterization and Potential Applications. Elsevier; 2020. pp. 265-306. [DOI: 10.1016/b978-0-08-102828-5.00011-5] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Jahnsen J, Detlie TE, Vatn S, Ricanek P. Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study. Expert Rev Gastroenterol Hepatol. 2015;9 Suppl 1:45-52. [PMID: 26395534 DOI: 10.1586/17474124.2015.1091308] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 12.2] [Reference Citation Analysis]
16 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Reference Citation Analysis]
17 Orbán C, Szabó D, Bajnok A, Vásárhelyi B, Tulassay T, Arató A, Veres G, Toldi G. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns. Oncotarget 2016;7:44966-74. [PMID: 27329601 DOI: 10.18632/oncotarget.10036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
18 Meiners J, Palmieri V, Klopfleisch R, Ebel JF, Japtok L, Schumacher F, Yusuf AM, Becker KA, Zöller J, Hose M, Kleuser B, Hermann DM, Kolesnick RN, Buer J, Hansen W, Westendorf AM. Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis. Front Immunol 2019;10:1386. [PMID: 31275322 DOI: 10.3389/fimmu.2019.01386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
19 Baritaki S, de Bree E, Chatzaki E, Pothoulakis C. Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk. J Clin Med 2019;8:E1669. [PMID: 31614860 DOI: 10.3390/jcm8101669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
20 Sen ES, Ramanan AV. New age of biological therapies in paediatric rheumatology. Arch Dis Child 2014;99:679-85. [PMID: 24621445 DOI: 10.1136/archdischild-2013-304396] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
21 Ghaleb AM, Laroui H, Merlin D, Yang VW. Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-κB pathway inflammatory response. Inflamm Bowel Dis 2014;20:811-20. [PMID: 24681655 DOI: 10.1097/MIB.0000000000000022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
22 Tahir AH, Wan J, Shah MK, Janyaro H, Li XJ, Ding MX. A novel model for studying ileitis-induced visceral hypersensitivity in goats. Acta Vet Scand 2016;58:72. [PMID: 27716368 DOI: 10.1186/s13028-016-0253-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Gologan S, Iacob R, Iancu D, Iacob S, Cotruta B, Vadan R, Catuneanu AM, Constantinescu I, Barbarii L, Gheorghe C. Inflammatory gene expression profiles in Crohn’s disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol. J Crohns Colitis. 2013;7:622-630. [PMID: 23014361 DOI: 10.1016/j.crohns.2012.08.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
24 Sisto M, Ribatti D, Lisi S. Aquaporin water channels: New perspectives on the potential role in inflammation. Adv Protein Chem Struct Biol 2019;116:311-45. [PMID: 31036295 DOI: 10.1016/bs.apcsb.2018.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
25 Adjouzem CF, Gilbert A, Mbiantcha M, Yousseu Nana W, Matah Marthe Mba V, Djuichou Nguemnang SF, Tsafack EG, Atsamo AD. Effects of Aqueous and Methanolic Extracts of Stem Bark of Alstonia boonei De Wild. (Apocynaceae) on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Wistar Rats. Evid Based Complement Alternat Med 2020;2020:4918453. [PMID: 32565862 DOI: 10.1155/2020/4918453] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Martin FP, Lichti P, Bosco N, Brahmbhatt V, Oliveira M, Haller D, Benyacoub J. Metabolic phenotyping of an adoptive transfer mouse model of experimental colitis and impact of dietary fish oil intake. J Proteome Res. 2015;14:1911-1919. [PMID: 25751005 DOI: 10.1021/pr501299m] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
27 Dou X, Gao N, Yan D, Shan A. Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis. Animals (Basel) 2020;10:E1154. [PMID: 32645998 DOI: 10.3390/ani10071154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
28 Thapa B, Pak S, Kwon HJ, Lee K. Decursinol Angelate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Modulating Type 17 Helper T Cell Responses. Biomol Ther (Seoul) 2019;27:466-73. [PMID: 30917627 DOI: 10.4062/biomolther.2019.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ginwala R, Bhavsar R, Chigbu DI, Jain P, Khan ZK. Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin. Antioxidants (Basel) 2019;8:E35. [PMID: 30764536 DOI: 10.3390/antiox8020035] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 23.7] [Reference Citation Analysis]
30 Hossian AKMN, Mackenzie GG, Mattheolabakis G. miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally? Nanomedicine (Lond) 2019;14:2873-89. [PMID: 31735124 DOI: 10.2217/nnm-2019-0180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Chotikatum S, Naim HY, El-najjar N. Inflammation induced ER stress affects absorptive intestinal epithelial cells function and integrity. International Immunopharmacology 2018;55:336-44. [DOI: 10.1016/j.intimp.2017.12.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
32 Abtahi Froushani SM, Mashouri S. The Beneficial Effects of Hypiran in Ameliorating Rat Model of Ulcerative Colitis. Zahedan J Res Med Sci 2018;20. [DOI: 10.5812/zjrms.58919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res 2016;176:38-68. [PMID: 27220087 DOI: 10.1016/j.trsl.2016.04.009] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 14.2] [Reference Citation Analysis]
34 Zhao H, Zhang H, Wu H, Li H, Liu L, Guo J, Li C, Shih DQ, Zhang X. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol 2012;12:57. [PMID: 22647055 DOI: 10.1186/1471-230X-12-57] [Cited by in Crossref: 141] [Cited by in F6Publishing: 89] [Article Influence: 14.1] [Reference Citation Analysis]
35 Zhao X, Liu J, Zhang C, Yu N, Lu Z, Zhang S, Li Y, Li Q, Liu J, Liu D, Pan Y. Porphyromonas gingivalis exacerbates ulcerative colitis via Porphyromonas gingivalis peptidylarginine deiminase. Int J Oral Sci 2021;13:31. [PMID: 34593756 DOI: 10.1038/s41368-021-00136-2] [Reference Citation Analysis]
36 Shajib MS, Chauhan U, Adeeb S, Chetty Y, Armstrong D, Halder SLS, Marshall JK, Khan WI. Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease. J Can Assoc Gastroenterol. 2019;2:132-140. [PMID: 31294376 DOI: 10.1093/jcag/gwy039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
37 Kayali S, Gaiani F, Manfredi M, Minelli R, Nervi G, Nouvenne A, Leandro G, Di Mario F, De' Angelis GL. Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? Acta Biomed 2018;89:81-6. [PMID: 30561399 DOI: 10.23750/abm.v89i9-S.7878] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Park A, Kim S, Jung IH, Byun JH. An immune therapy model for effective treatment on inflammatory bowel disease. PLoS One 2020;15:e0238918. [PMID: 32970698 DOI: 10.1371/journal.pone.0238918] [Reference Citation Analysis]
39 Hou Q, Ye L, Liu H, Huang L, Yang Q, Turner JR, Yu Q. Lactobacillus accelerates ISCs regeneration to protect the integrity of intestinal mucosa through activation of STAT3 signaling pathway induced by LPLs secretion of IL-22. Cell Death Differ 2018;25:1657-70. [PMID: 29459771 DOI: 10.1038/s41418-018-0070-2] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 21.8] [Reference Citation Analysis]
40 Pistol GC, Bulgaru CV, Marin DE, Oancea AG, Taranu I. Dietary Grape Seed Meal Bioactive Compounds Alleviate Epithelial Dysfunctions and Attenuates Inflammation in Colon of DSS-Treated Piglets. Foods 2021;10:530. [PMID: 33806347 DOI: 10.3390/foods10030530] [Reference Citation Analysis]
41 Morampudi V, Dalwadi U, Bhinder G, Sham HP, Gill SK, Chan J, Bergstrom KS, Huang T, Ma C, Jacobson K, Gibson DL, Vallance BA. The goblet cell-derived mediator RELM-β drives spontaneous colitis in Muc2-deficient mice by promoting commensal microbial dysbiosis. Mucosal Immunol 2016;9:1218-33. [PMID: 26813339 DOI: 10.1038/mi.2015.140] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 8.2] [Reference Citation Analysis]
42 Neubauer K, Woźniak-Stolarska B, Krzystek-Korpacka M. Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results. Biomed Res Int 2018;2018:4961753. [PMID: 30515402 DOI: 10.1155/2018/4961753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
43 Ehteshami-Afshar S, Nikfar S, Rezaie A, Abdollahi M. A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease. Arch Med Sci. 2011;7:1000-1012. [PMID: 22328883 DOI: 10.5114/aoms.2011.26612] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
44 Rana M, Coshic P, Goswami R, Tyagi RK. Influence of a critical single nucleotide polymorphism on nuclear receptor PXR-promoter function: PXR-promoter polymorphism. Cell Biol Int 2017;41:570-6. [DOI: 10.1002/cbin.10744] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
45 Balmus IM, Ciobica A, Cojocariu R, Luca AC, Gorgan L. Irritable Bowel Syndrome and Neurological Deficiencies: Is There A Relationship? The Possible Relevance of the Oxidative Stress Status. Medicina (Kaunas) 2020;56:E175. [PMID: 32295083 DOI: 10.3390/medicina56040175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Li N, Shi RH. Updated review on immune factors in pathogenesis of Crohn’s disease. World J Gastroenterol 2018; 24(1): 15-22 [PMID: 29358878 DOI: 10.3748/wjg.v24.i1.15] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
47 Kapadia BH, Issa K, Nagrare N, Pivec R, Banerjee S, Mont MA. Higher revision and complication rates following total hip arthroplasty in patients with inflammatory bowel disease. J Arthroplasty. 2014;29:596-600. [PMID: 24231436 DOI: 10.1016/j.arth.2013.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
48 Alley K, Singla A, Afzali A. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1990-5. [PMID: 31087042 DOI: 10.1093/ibd/izz100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
49 Khan N, Trivedi C, Kavani H, Lewis J, Yang YX. Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients. Inflamm Bowel Dis 2019;25:345-51. [PMID: 29982646 DOI: 10.1093/ibd/izy232] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
50 Ray A, Dittel BN. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology 2015;146:359-68. [PMID: 26211540 DOI: 10.1111/imm.12511] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
51 Bosca-Watts MM, Tosca J, Anton R, Mora M, Minguez M, Mora F. Pathogenesis of Crohn’s disease: Bug or no bug. World J Gastrointest Pathophysiol 2015; 6(1): 1-12 [PMID: 25685606 DOI: 10.4291/wjgp.v6.i1.1] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
52 Comito D, Romano C. Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases. Int J Inflam. 2012;2012:687143. [PMID: 22685684 DOI: 10.1155/2012/687143] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
53 Han F, Zhang H, Xia X, Xiong H, Song D, Zong X, Wang Y. Porcine β-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis. J Immunol 2015;194:1882-93. [PMID: 25601921 DOI: 10.4049/jimmunol.1402300] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 12.4] [Reference Citation Analysis]
54 Durmus A, Durmus I, Bender O, Karatepe O. The effect of Hericium erinaceum on the prevention of chemically induced experimental colitis in rats. Korean J Intern Med 2021;36:S44-52. [PMID: 32550720 DOI: 10.3904/kjim.2019.050] [Reference Citation Analysis]
55 Paiatto LN, Silva FGD, Yamada ÁT, Tamashiro WMSC, Simioni PU. Adoptive transfer of dendritic cells expressing CD11c reduces the immunological response associated with experimental colitis in BALB/c mice. PLoS One 2018;13:e0196994. [PMID: 29738575 DOI: 10.1371/journal.pone.0196994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Adesso S, Russo R, Quaroni A, Autore G, Marzocco S. Astragalus membranaceus Extract Attenuates Inflammation and Oxidative Stress in Intestinal Epithelial Cells via NF-κB Activation and Nrf2 Response. Int J Mol Sci 2018;19:E800. [PMID: 29534459 DOI: 10.3390/ijms19030800] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
57 Kirchgessner A. The Role of the Microbiota and Potential for Dietary Intervention in Chronic Fatigue Syndrome. The Gut-Brain Axis. Elsevier; 2016. pp. 439-63. [DOI: 10.1016/b978-0-12-802304-4.00021-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Buccioni M, Dal Ben D, Lambertucci C, Martí Navia A, Ricciutelli M, Spinaci A, Volpini R, Marucci G. New sensible method to quantize the intestinal absorption of receptor ligands. Bioorg Med Chem 2019;27:3328-33. [PMID: 31230970 DOI: 10.1016/j.bmc.2019.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Mukherjee S, Joardar N, Sengupta S, Sinha Babu SP. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. J Nutr Biochem 2018;61:111-28. [PMID: 30196243 DOI: 10.1016/j.jnutbio.2018.07.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
60 Volarevic V, Zdravkovic N, Harrell CR, Arsenijevic N, Fellabaum C, Djonov V, Lukic ML, Simovic Markovic B. Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis. Cells 2019;8:E709. [PMID: 31336879 DOI: 10.3390/cells8070709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
61 Krawczyk A, Salamon D, Kowalska-Duplaga K, Bogiel T, Gosiewski T. Association of Fungi and Archaea of the Gut Microbiota with Crohn's Disease in Pediatric Patients-Pilot Study. Pathogens 2021;10:1119. [PMID: 34578152 DOI: 10.3390/pathogens10091119] [Reference Citation Analysis]
62 Piechota-Polanczyk A, Włodarczyk M, Sobolewska-Włodarczyk A, Jonakowski M, Pilarczyk A, Stec-Michalska K, Wiśniewska-Jarosińska M, Fichna J. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease. Dig Dis Sci 2017;62:1511-7. [PMID: 28391416 DOI: 10.1007/s10620-017-4568-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
63 Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. International Journal of Pharmaceutics 2019;558:201-14. [DOI: 10.1016/j.ijpharm.2018.12.074] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
64 Kashem MA, Li L, Yuan X, Plummer FA, Luo M. Toll-like Interleukin -1 Receptor Regulator (TILRR) Protein, a Major Modulator of Inflammation, is Expressed in Normal Human and Macaque Tissues and PBMCs. JIR 2022;Volume 15:2925-37. [DOI: 10.2147/jir.s357866] [Reference Citation Analysis]
65 Yang Y, Zhu X, Qin Y, Chen G, Zhou J, Li L, Guan J, Ma L, Xue Y, Li C. The Anti-Inflammatory Effect of Guchangzhixie-Pill by Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in an Ulcerative Colitis Rat Model. Evid Based Complement Alternat Med 2017;2017:8547257. [PMID: 28845184 DOI: 10.1155/2017/8547257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
66 Chaparro M, Aterido A, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Barreiro-de Acosta M, Vera I, Martín-Arranz MD, Hernández-Breijo B, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Bermejo F, Beltrán B, Rodríguez-Pescador A, Banales JM, Olivares D, Aguilar-Melero P, Menchén L, Ferreiro-Iglesias R, Blazquez Gómez I, Benitez García B, Guijarro LG, Marin AC, Bernardo D, Marsal S, Julia A, Gisbert JP. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease. Therap Adv Gastroenterol 2019;12:1756284819867848. [PMID: 31598133 DOI: 10.1177/1756284819867848] [Reference Citation Analysis]
67 Yuan D, Li C, Huang Q, Fu X, Dong H. Current advances in the anti-inflammatory effects and mechanisms of natural polysaccharides. Crit Rev Food Sci Nutr 2022;:1-21. [PMID: 35021901 DOI: 10.1080/10408398.2022.2025535] [Reference Citation Analysis]
68 Kristjánsson VB, Lund SH, Gröndal G, Sveinsdóttir SV, Agnarsson HR, Jónasson JG, Björnsson ES. Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018. Scand J Gastroenterol 2021;56:46-52. [PMID: 33280485 DOI: 10.1080/00365521.2020.1854847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
69 Banskota S, Regmi SC, Gautam J, Gurung P, Lee YJ, Ku SK, Lee JH, Lee J, Chang HW, Park SJ, Kim JA. Serotonin disturbs colon epithelial tolerance of commensal E. coli by increasing NOX2-derived superoxide. Free Radic Biol Med 2017;106:196-207. [PMID: 28216386 DOI: 10.1016/j.freeradbiomed.2017.02.034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
70 Gerges SH, Tolba MF, Elsherbiny DA, El-Demerdash E. The natural flavonoid galangin ameliorates dextran sulphate sodium-induced ulcerative colitis in mice: Effect on Toll-like receptor 4, inflammation and oxidative stress. Basic Clin Pharmacol Toxicol 2020;127:10-20. [PMID: 31943791 DOI: 10.1111/bcpt.13388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
71 Brandhorst G, Weigand S, Eberle C, Raddatz D, Karaus M, Oellerich M, Walson PD. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Clin Chim Acta. 2013;421:31-33. [PMID: 23485644 DOI: 10.1016/j.cca.2013.02.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
72 Yadav S, Kumar R, Jaiyesimi IA, Chisti MM. Aggressive plasmablastic multiple myeloma in a 42-year-old: is inflammatory bowel disease or infliximab treatment to be blamed? BMJ Case Rep 2013;2013:bcr2013200607. [PMID: 24169869 DOI: 10.1136/bcr-2013-200607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Naghdalipour M, Moradi N, Fadaei R, Rezghi Barez S, Sayyahfar S, Mokhtare M, Fard TK, Fallah S, Esteghamati A. Alteration of miR-21, miR-433 and miR-590 tissue expression related to the TGF-β signaling pathway in ulcerative colitis patients. Archives of Physiology and Biochemistry. [DOI: 10.1080/13813455.2020.1762656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Gnauck A, Lentle RG, Kruger MC. Chasing a ghost?--Issues with the determination of circulating levels of endotoxin in human blood. Crit Rev Clin Lab Sci 2016;53:197-215. [PMID: 26732012 DOI: 10.3109/10408363.2015.1123215] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
75 Barreau F, Tisseyre C, Ménard S, Ferrand A, Carriere M. Titanium dioxide particles from the diet: involvement in the genesis of inflammatory bowel diseases and colorectal cancer. Part Fibre Toxicol 2021;18:26. [PMID: 34330311 DOI: 10.1186/s12989-021-00421-2] [Reference Citation Analysis]
76 Holgersen K, Kvist PH, Hansen AK, Holm TL. Predictive validity and immune cell involvement in the pathogenesis of piroxicam-accelerated colitis in interleukin-10 knockout mice. International Immunopharmacology 2014;21:137-47. [DOI: 10.1016/j.intimp.2014.04.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
77 Lippai R, Veres-Székely A, Sziksz E, Iwakura Y, Pap D, Rokonay R, Szebeni B, Lotz G, Béres NJ, Cseh Á, Szabó AJ, Vannay Á. Immunomodulatory role of Parkinson's disease 7 in inflammatory bowel disease. Sci Rep 2021;11:14582. [PMID: 34272410 DOI: 10.1038/s41598-021-93671-1] [Reference Citation Analysis]
78 Lv J, Zhang Y, Tian Z, Liu F, Shi Y, Liu Y, Xia P. Astragalus polysaccharides protect against dextran sulfate sodium-induced colitis by inhibiting NF-κВ activation. Int J Biol Macromol 2017;98:723-9. [PMID: 28188801 DOI: 10.1016/j.ijbiomac.2017.02.024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
79 Siczek K, Zatorski H, Chmielowiec-Korzeniowska A, Pulit-Prociak J, Śmiech M, Kordek R, Tymczyna L, Banach M, Fichna J. Synthesis and evaluation of anti-inflammatory properties of silver nanoparticle suspensions in experimental colitis in mice. Chem Biol Drug Des 2017;89:538-47. [PMID: 27696734 DOI: 10.1111/cbdd.12876] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
80 Ferreira RB, Willing BP, Finlay BB. Bringing Koch's postulates to the table in IBD. Cell Host Microbe 2011;9:353-4. [PMID: 21575906 DOI: 10.1016/j.chom.2011.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
81 Mirza-Aghazadeh-Attari M, Mohammadzadeh A, Mostavafi S, Mihanfar A, Ghazizadeh S, Sadighparvar S, Gholamzadeh S, Majidinia M, Yousefi B. Melatonin: An important anticancer agent in colorectal cancer. J Cell Physiol 2020;235:804-17. [PMID: 31276205 DOI: 10.1002/jcp.29049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
82 Chen Y, Wang C, Liu Y, Tang L, Zheng M, Xu C, Song J, Meng X. miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn’s disease. Biochem Biophys Res Commun. 2013;438:133-139. [PMID: 23872065 DOI: 10.1016/j.bbrc.2013.07.040] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
83 Hu J, Mei Q, Huang J, Hu NZ, Liu XC, Xu JM. Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population. World J Gastroenterol 2014; 20(23): 7466-7472 [PMID: 24966617 DOI: 10.3748/wjg.v20.i23.7466] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
84 Bugda Gwilt K, Olliffe N, Hoffing RA, Miller GM. Trace amine associated receptor 1 (TAAR1) expression and modulation of inflammatory cytokine production in mouse bone marrow-derived macrophages: a novel mechanism for inflammation in ulcerative colitis. Immunopharmacology and Immunotoxicology 2019;41:577-85. [DOI: 10.1080/08923973.2019.1672178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
85 Fernandes C, Wanderley CWS, Silva CMS, Muniz HA, Teixeira MA, Souza NRP, Cândido AGF, Falcão RB, Souza MHLP, Almeida PRC, Câmara LMC, Lima-Júnior RCP. Role of regulatory T cells in irinotecan-induced intestinal mucositis. Eur J Pharm Sci 2018;115:158-66. [PMID: 29307857 DOI: 10.1016/j.ejps.2018.01.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
86 Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol. 2020;17:597-617. [PMID: 32710014 DOI: 10.1038/s41575-020-0331-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
87 Ran X, Li Y, Chen G, Fu S, He D, Huang B, Wei L, Lin Y, Guo Y, Hu G. Farrerol Ameliorates TNBS-Induced Colonic Inflammation by Inhibiting ERK1/2, JNK1/2, and NF-κB Signaling Pathway. Int J Mol Sci 2018;19:E2037. [PMID: 30011811 DOI: 10.3390/ijms19072037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
88 Hou Q, Ye L, Huang L, Yu Q. The Research Progress on Intestinal Stem Cells and Its Relationship with Intestinal Microbiota. Front Immunol 2017;8:599. [PMID: 28588586 DOI: 10.3389/fimmu.2017.00599] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
89 LeBlanc AM, LeBlanc JG. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. World J Gastroenterol 2014; 20(44): 16518-16528 [PMID: 25469019 DOI: 10.3748/wjg.v20.i44.16518] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
90 Al-Meghaiseeb ES, Al-Otaibi MM, Al-Robayan A, Al-Amro R, Al-Malki AS, Arfin M, Al-Asmari AK. Genetic association of apolipoprotein E polymorphisms with inflammatory bowel disease. World J Gastroenterol 2015; 21(3): 897-904 [PMID: 25624723 DOI: 10.3748/wjg.v21.i3.897] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
91 Wang W, Jovel J, Halloran B, Wine E, Patterson J, Ford G, O'Keefe S, Meng B, Song D, Zhang Y. Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflamm Bowel Dis. 2015;21:1419-1427. [PMID: 25939040 DOI: 10.1097/mib.0000000000000344] [Cited by in Crossref: 25] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
92 Sasaki M, Klapproth JM. The role of bacteria in the pathogenesis of ulcerative colitis. J Signal Transduct 2012;2012:704953. [PMID: 22619714 DOI: 10.1155/2012/704953] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
93 Alhagamhmad MH, Day AS, Lemberg DA, Leach ST. An overview of the bacterial contribution to Crohn disease pathogenesis. Journal of Medical Microbiology 2016;65:1049-59. [DOI: 10.1099/jmm.0.000331] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
94 Yuan H, Zhao XM, Yuan ZY, Wang HM, Zhao WH. Treatment with Carthamus Tinctorius Injection up-regulates IL-4 expression and down-regulates IL-1β expression in ulcerative colitis in rats. Shijie Huaren Xiaohua Zazhi 2012; 20(36): 3678-3682 [DOI: 10.11569/wcjd.v20.i36.3678] [Reference Citation Analysis]
95 Cano PM, Seeboth J, Meurens F, Cognie J, Abrami R, Oswald IP, Guzylack-Piriou L. Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging hypothesis through possible modulation of Th17-mediated response. PLoS One 2013;8:e53647. [PMID: 23326479 DOI: 10.1371/journal.pone.0053647] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 8.4] [Reference Citation Analysis]
96 Mandlik DS, Mandlik SK, Patel S. Protective effect of sarsasapogenin in TNBS induced ulcerative colitis in rats associated with downregulation of pro-inflammatory mediators and oxidative stress. Immunopharmacol Immunotoxicol 2021;:1-13. [PMID: 34338577 DOI: 10.1080/08923973.2021.1955919] [Reference Citation Analysis]
97 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
98 Al-toma A, Nijeboer P, Bouma G, Visser O, Mulder CJ. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J Gastroenterol 2014; 20(46): 17368-17375 [PMID: 25516648 DOI: 10.3748/wjg.v20.i46.17368] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
99 Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients 2020;12:E2097. [PMID: 32679784 DOI: 10.3390/nu12072097] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 39.5] [Reference Citation Analysis]
100 Bui TM, Sumagin R. Progressing from Recurring Tissue Injury to Genomic Instability: A New Mechanism of Neutrophil Pathogenesis. DNA Cell Biol 2019;38:747-53. [PMID: 31188020 DOI: 10.1089/dna.2019.4842] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
101 Martins FS. Fecal Microbiota Transplantation for Ulcerative Colitis: FoMenTing Change? Dig Dis Sci 2016;61:2154-5. [DOI: 10.1007/s10620-016-4133-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
102 Galatola M, Miele E, Strisciuglio C, Paparo L, Rega D, Delrio P, Duraturo F, Martinelli M, Rossi GB, Staiano A, Izzo P, Rosa MD. Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis. World J Gastroenterol 2013; 19(46): 8659-8670 [PMID: 24379584 DOI: 10.3748/wjg.v19.i46.8659] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
103 Pascual V, Dieli-Crimi R, López-Palacios N, Bodas A, Medrano LM, Núñez C. Inflammatory bowel disease and celiac disease: Overlaps and differences. World J Gastroenterol 2014; 20(17): 4846-4856 [PMID: 24803796 DOI: 10.3748/wjg.v20.i17.4846] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
104 Lin MJ, Lv XP, Chen L, Zhan LL. Correlation of R702W, G908R and L1007fs polymorphisms of the NOD2/CARD15 gene with susceptibility to inflammatory bowel disease in Zhuang population in Guangxi, China. Shijie Huaren Xiaohua Zazhi 2012; 20(14): 1210-1215 [DOI: 10.11569/wcjd.v20.i14.1210] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Balbas-Martinez V, Ruiz-Cerdá L, Irurzun-Arana I, González-García I, Vermeulen A, Gómez-Mantilla JD, Trocóniz IF. A systems pharmacology model for inflammatory bowel disease. PLoS One 2018;13:e0192949. [PMID: 29513758 DOI: 10.1371/journal.pone.0192949] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
106 Comito D, Cascio A, Romano C. Microbiota biodiversity in inflammatory bowel disease. Ital J Pediatr 2014;40:32. [PMID: 24684926 DOI: 10.1186/1824-7288-40-32] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
107 Foroutan P, Boshagh MA, Moloudi MR, Fakhari S, Nikkhoo B, Jalili A. Expression of CXC Chemokine Receptors in Acute Ulcerative Colitis: Initial Study from an Animal Model. Adv Biomed Res 2019;8:56. [PMID: 31673529 DOI: 10.4103/abr.abr_55_19] [Reference Citation Analysis]
108 Zhu Y, Yang S, Zhao N, Liu C, Zhang F, Guo Y, Liu H. CXCL8 chemokine in ulcerative colitis. Biomed Pharmacother 2021;138:111427. [PMID: 33706134 DOI: 10.1016/j.biopha.2021.111427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
109 Wang RX, Zhou M, Ma HL, Qiao YB, Li QS. The Role of Chronic Inflammation in Various Diseases and Anti-inflammatory Therapies Containing Natural Products. ChemMedChem 2021;16:1576-92. [PMID: 33528076 DOI: 10.1002/cmdc.202000996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 de Santana Souza MT, Teixeira DF, de Oliveira JP, Oliveira AS, Quintans-Júnior LJ, Correa CB, Camargo EA. Protective effect of carvacrol on acetic acid-induced colitis. Biomed Pharmacother 2017;96:313-9. [PMID: 29017143 DOI: 10.1016/j.biopha.2017.10.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
111 Al-toma A, Nijeboer P, Bouma G, Visser O, Mulder CJ. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J Gastroenterol 2014;20:17368-75. [PMID: 25516648 DOI: 10.3748/wjg.v20.i46.17368] [Reference Citation Analysis]
112 Zobeiri M, Momtaz S, Parvizi F, Tewari D, Farzaei MH, Nabavi SM. Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases. Curr Pharm Biotechnol 2020;21:1342-53. [PMID: 31840607 DOI: 10.2174/1389201021666191216122555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
113 Lauro R, Mannino F, Irrera N, Squadrito F, Altavilla D, Squadrito G, Pallio G, Bitto A. Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review. Biomedicines 2021;9:1748. [PMID: 34944563 DOI: 10.3390/biomedicines9121748] [Reference Citation Analysis]
114 Øyri SF, Műzes G, Sipos F. Dysbiotic gut microbiome: A key element of Crohn's disease. Comp Immunol Microbiol Infect Dis 2015;43:36-49. [PMID: 26616659 DOI: 10.1016/j.cimid.2015.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
115 Sangaraju R, Nalban N, Alavala S, Rajendran V, Jerald MK, Sistla R. Protective effect of galangin against dextran sulfate sodium (DSS)-induced ulcerative colitis in Balb/c mice. Inflamm Res 2019;68:691-704. [PMID: 31147743 DOI: 10.1007/s00011-019-01252-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
116 Wei X, Kenny JR, Dickmann L, Maciuca R, Looney C, Tang MT. Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis. J Clin Pharmacol. 2016;56:693-704. [PMID: 26412221 DOI: 10.1002/jcph.649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
117 Shen P, Zhang Z, Zhu K, Cao H, Liu J, Lu X, Li Y, Jing Y, Yuan X, Fu Y, Cao Y, Zhang N. Evodiamine prevents dextran sulfate sodium-induced murine experimental colitis via the regulation of NF-κB and NLRP3 inflammasome. Biomed Pharmacother 2019;110:786-95. [PMID: 30554117 DOI: 10.1016/j.biopha.2018.12.033] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
118 Lim SZ, Chua EW. Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring. Front Pharmacol. 2018;9:1107. [PMID: 30349479 DOI: 10.3389/fphar.2018.01107] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
119 Rufino MN, Aleixo GFP, Trombine-Batista IE, Giuffrida R, Keller R, Bremer-Neto H. Systematic review and meta-analysis of preclinical trials demonstrate robust beneficial effects of prebiotics in induced inflammatory bowel disease. J Nutr Biochem. 2018;62:1-8. [PMID: 30053633 DOI: 10.1016/j.jnutbio.2018.05.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
120 Glick LR, Sossenheimer PH, Ollech JE, Cohen RD, Hyman NH, Hurst RD, Rubin DT. Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study. J Crohns Colitis. 2019;13:1158-1162. [PMID: 30809655 DOI: 10.1093/ecco-jcc/jjz047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
121 Amaldoss MJN, Najar IA, Kumar J, Sharma A. Therapeutic efficacy of rifaximin loaded tamarind gum polysaccharide nanoparticles in TNBS induced IBD model Wistar rats. Rep Pract Oncol Radiother 2021;26:712-29. [PMID: 34760306 DOI: 10.5603/RPOR.a2021.0100] [Reference Citation Analysis]
122 Lucena AMM, Souza CRM, Jales JT, Guedes PMM, de Miranda GEC, de Moura AMA, Araújo-Júnior JX, Nascimento GJ, Scortecci KC, Santos BVO, Souto JT. The Bisindole Alkaloid Caulerpin, from Seaweeds of the Genus Caulerpa, Attenuated Colon Damage in Murine Colitis Model. Mar Drugs 2018;16:E318. [PMID: 30205459 DOI: 10.3390/md16090318] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
123 Khasawneh M, Spence AD, Addley J, Allen PB. The role of smoking and alcohol behaviour in the management of inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2017;31:553-559. [PMID: 29195675 DOI: 10.1016/j.bpg.2017.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
124 Zargar A, Gooraji SA, Keshavarzi B, Haji Aghamohammadi AA. Effect of Irritable Bowel Syndrome on Sleep Quality and Quality of Life of Inflammatory Bowel Disease in Clinical Remission. Int J Prev Med 2019;10:10. [PMID: 30774844 DOI: 10.4103/ijpvm.IJPVM_364_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
125 Sen ES, Ramanan AV. Republished: new age of biological therapies in paediatric rheumatology. Postgrad Med J 2014;90:590-6. [PMID: 25230947 DOI: 10.1136/postgradmedj-2013-304396rep] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
127 Lv QK, Liu JX, Li SN, Gao YJ, Lv Y, Xu ZP, Huang BX, Xu SY, Yang DX, Zeng YL, Liu DF, Wang W. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model. Int J Mol Sci 2015;16:26654-66. [PMID: 26561804 DOI: 10.3390/ijms161125985] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]